nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—FCGR activation—FYN—stomach cancer	0.0299	0.0881	CbGpPWpGaD
Methyl aminolevulinate—Burning sensation—Mitomycin—stomach cancer	0.0217	0.0329	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—MT2A—stomach cancer	0.0202	0.0595	CbGpPWpGaD
Methyl aminolevulinate—Scab—Fluorouracil—stomach cancer	0.0197	0.0299	CcSEcCtD
Methyl aminolevulinate—Stinging—Mitomycin—stomach cancer	0.0186	0.0282	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Fluorouracil—stomach cancer	0.018	0.0272	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—XAF1—stomach cancer	0.0175	0.0516	CbGpPWpGaD
Methyl aminolevulinate—Localized exfoliation—Capecitabine—stomach cancer	0.0163	0.0247	CcSEcCtD
Methyl aminolevulinate—Ulcer—Mitomycin—stomach cancer	0.016	0.0242	CcSEcCtD
Methyl aminolevulinate—Scab—Capecitabine—stomach cancer	0.0138	0.0209	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CTSL—stomach cancer	0.0132	0.039	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IRF1—stomach cancer	0.0121	0.0356	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—XAF1—stomach cancer	0.0117	0.0345	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Floxuridine—stomach cancer	0.011	0.0167	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Fluorouracil—stomach cancer	0.0106	0.016	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—CD44—stomach cancer	0.0105	0.0309	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MT2A—stomach cancer	0.00987	0.0291	CbGpPWpGaD
Methyl aminolevulinate—Blister—Fluorouracil—stomach cancer	0.00871	0.0132	CcSEcCtD
Methyl aminolevulinate—Sensitisation—Epirubicin—stomach cancer	0.00856	0.013	CcSEcCtD
Methyl aminolevulinate—Erythema—Floxuridine—stomach cancer	0.00841	0.0127	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MX1—stomach cancer	0.00805	0.0237	CbGpPWpGaD
Methyl aminolevulinate—Sensitisation—Doxorubicin—stomach cancer	0.00792	0.012	CcSEcCtD
Methyl aminolevulinate—Stinging—Fluorouracil—stomach cancer	0.00775	0.0117	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Docetaxel—stomach cancer	0.00762	0.0115	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Capecitabine—stomach cancer	0.00738	0.0112	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Fluorouracil—stomach cancer	0.00735	0.0111	CcSEcCtD
Methyl aminolevulinate—Discomfort—Floxuridine—stomach cancer	0.00707	0.0107	CcSEcCtD
Methyl aminolevulinate—Ulcer—Irinotecan—stomach cancer	0.00693	0.0105	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—FYN—stomach cancer	0.00692	0.0204	CbGpPWpGaD
Methyl aminolevulinate—Infection—Floxuridine—stomach cancer	0.00682	0.0103	CcSEcCtD
Methyl aminolevulinate—Keratitis—Capecitabine—stomach cancer	0.00677	0.0102	CcSEcCtD
Methyl aminolevulinate—Ulcer—Fluorouracil—stomach cancer	0.00664	0.0101	CcSEcCtD
Methyl aminolevulinate—Erythema—Mitomycin—stomach cancer	0.0066	0.00999	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MT2A—stomach cancer	0.00659	0.0194	CbGpPWpGaD
Methyl aminolevulinate—Burning sensation—Docetaxel—stomach cancer	0.00652	0.00988	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CA—stomach cancer	0.00629	0.0185	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis contact—Fluorouracil—stomach cancer	0.00621	0.0094	CcSEcCtD
Methyl aminolevulinate—Blister—Capecitabine—stomach cancer	0.00609	0.00922	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IRF1—stomach cancer	0.0059	0.0174	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM2—stomach cancer	0.00586	0.0172	CbGpPWpGaD
Methyl aminolevulinate—Skin ulcer—Capecitabine—stomach cancer	0.00564	0.00854	CcSEcCtD
Methyl aminolevulinate—Discomfort—Mitomycin—stomach cancer	0.00555	0.00841	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Methotrexate—stomach cancer	0.00549	0.00832	CcSEcCtD
Methyl aminolevulinate—Oedema—Mitomycin—stomach cancer	0.00539	0.00816	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MX1—stomach cancer	0.00537	0.0158	CbGpPWpGaD
Methyl aminolevulinate—Eye irritation—Docetaxel—stomach cancer	0.00531	0.00804	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CTSL—stomach cancer	0.00529	0.0156	CbGpPWpGaD
Methyl aminolevulinate—Swelling—Fluorouracil—stomach cancer	0.00517	0.00782	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Epirubicin—stomach cancer	0.00514	0.00778	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Capecitabine—stomach cancer	0.00514	0.00778	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—CD44—stomach cancer	0.00513	0.0151	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Floxuridine—stomach cancer	0.00506	0.00766	CcSEcCtD
Methyl aminolevulinate—Asthenia—Floxuridine—stomach cancer	0.00492	0.00746	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Fluorouracil—stomach cancer	0.00477	0.00722	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Doxorubicin—stomach cancer	0.00476	0.0072	CcSEcCtD
Methyl aminolevulinate—Keratitis—Epirubicin—stomach cancer	0.00471	0.00714	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Methotrexate—stomach cancer	0.0047	0.00712	CcSEcCtD
Methyl aminolevulinate—Fatigue—Mitomycin—stomach cancer	0.00464	0.00703	CcSEcCtD
Methyl aminolevulinate—Ulcer—Capecitabine—stomach cancer	0.00464	0.00703	CcSEcCtD
Methyl aminolevulinate—Pain—Mitomycin—stomach cancer	0.00461	0.00697	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Epirubicin—stomach cancer	0.0044	0.00666	CcSEcCtD
Methyl aminolevulinate—Keratitis—Doxorubicin—stomach cancer	0.00436	0.0066	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—POLR3K—stomach cancer	0.00435	0.0128	CbGpPWpGaD
Methyl aminolevulinate—Rash—Floxuridine—stomach cancer	0.00433	0.00655	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Docetaxel—stomach cancer	0.00433	0.00655	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Floxuridine—stomach cancer	0.00432	0.00655	CcSEcCtD
Methyl aminolevulinate—Headache—Floxuridine—stomach cancer	0.0043	0.00651	CcSEcCtD
Methyl aminolevulinate—Blister—Epirubicin—stomach cancer	0.00424	0.00642	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Methotrexate—stomach cancer	0.0042	0.00635	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Capecitabine—stomach cancer	0.00419	0.00634	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PYCARD—stomach cancer	0.00412	0.0121	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Floxuridine—stomach cancer	0.00408	0.00617	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Doxorubicin—stomach cancer	0.00407	0.00617	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRF1—stomach cancer	0.00394	0.0116	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—MAPK3—stomach cancer	0.00394	0.0116	CbGpPWpGaD
Methyl aminolevulinate—Skin ulcer—Epirubicin—stomach cancer	0.00393	0.00595	CcSEcCtD
Methyl aminolevulinate—Blister—Doxorubicin—stomach cancer	0.00392	0.00594	CcSEcCtD
Methyl aminolevulinate—Asthenia—Mitomycin—stomach cancer	0.00386	0.00585	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Epirubicin—stomach cancer	0.00383	0.0058	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—XAF1—stomach cancer	0.00382	0.0113	CbGpPWpGaD
Methyl aminolevulinate—Stinging—Epirubicin—stomach cancer	0.00377	0.00571	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TXNIP—stomach cancer	0.00377	0.0111	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—MAPK1—stomach cancer	0.00375	0.011	CbGpPWpGaD
Methyl aminolevulinate—Swelling—Docetaxel—stomach cancer	0.00373	0.00565	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1RN—stomach cancer	0.00367	0.0108	CbGpPWpGaD
Methyl aminolevulinate—Skin ulcer—Doxorubicin—stomach cancer	0.00363	0.0055	CcSEcCtD
Methyl aminolevulinate—Swelling—Capecitabine—stomach cancer	0.00361	0.00547	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Fluorouracil—stomach cancer	0.0036	0.00545	CcSEcCtD
Methyl aminolevulinate—Dizziness—Mitomycin—stomach cancer	0.00356	0.00539	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM2—stomach cancer	0.00355	0.0105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSC—stomach cancer	0.00355	0.0104	CbGpPWpGaD
Methyl aminolevulinate—Rash pustular—Doxorubicin—stomach cancer	0.00355	0.00537	CcSEcCtD
Methyl aminolevulinate—Eye pain—Capecitabine—stomach cancer	0.00353	0.00534	CcSEcCtD
Methyl aminolevulinate—Stinging—Doxorubicin—stomach cancer	0.00349	0.00529	CcSEcCtD
Methyl aminolevulinate—Ulcer—Methotrexate—stomach cancer	0.00345	0.00523	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Docetaxel—stomach cancer	0.00344	0.00521	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CD44—stomach cancer	0.00342	0.0101	CbGpPWpGaD
Methyl aminolevulinate—Rash—Mitomycin—stomach cancer	0.0034	0.00514	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Mitomycin—stomach cancer	0.00339	0.00514	CcSEcCtD
Methyl aminolevulinate—Headache—Mitomycin—stomach cancer	0.00337	0.00511	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Capecitabine—stomach cancer	0.00333	0.00505	CcSEcCtD
Methyl aminolevulinate—Ulcer—Epirubicin—stomach cancer	0.00323	0.00489	CcSEcCtD
Methyl aminolevulinate—Nausea—Mitomycin—stomach cancer	0.0032	0.00484	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CASP10—stomach cancer	0.00312	0.00919	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Methotrexate—stomach cancer	0.00312	0.00472	CcSEcCtD
Methyl aminolevulinate—Face oedema—Capecitabine—stomach cancer	0.00308	0.00466	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Epirubicin—stomach cancer	0.00302	0.00457	CcSEcCtD
Methyl aminolevulinate—Ulcer—Doxorubicin—stomach cancer	0.00299	0.00453	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK3—stomach cancer	0.00297	0.00875	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Epirubicin—stomach cancer	0.00292	0.00442	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK1—stomach cancer	0.00283	0.00833	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis contact—Doxorubicin—stomach cancer	0.0028	0.00423	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BIRC2—stomach cancer	0.00275	0.0081	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Fluorouracil—stomach cancer	0.00275	0.00416	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CTSL—stomach cancer	0.00272	0.00802	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Doxorubicin—stomach cancer	0.0027	0.00409	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MALT1—stomach cancer	0.00266	0.00782	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—LGALS3—stomach cancer	0.00263	0.00775	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSL—stomach cancer	0.00262	0.0077	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—FYN—stomach cancer	0.00257	0.00756	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MALT1—stomach cancer	0.00255	0.00751	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—POLR3K—stomach cancer	0.00253	0.00745	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Capecitabine—stomach cancer	0.00251	0.00381	CcSEcCtD
Methyl aminolevulinate—Eczema—Epirubicin—stomach cancer	0.00247	0.00374	CcSEcCtD
Methyl aminolevulinate—Eye pain—Epirubicin—stomach cancer	0.00246	0.00372	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—stomach cancer	0.00245	0.00723	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Irinotecan—stomach cancer	0.00241	0.00365	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PYCARD—stomach cancer	0.0024	0.00707	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Irinotecan—stomach cancer	0.00234	0.00354	CcSEcCtD
Methyl aminolevulinate—Infection—Irinotecan—stomach cancer	0.00232	0.00352	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Epirubicin—stomach cancer	0.00232	0.00352	CcSEcCtD
Methyl aminolevulinate—Discomfort—Fluorouracil—stomach cancer	0.00231	0.0035	CcSEcCtD
Methyl aminolevulinate—Eczema—Doxorubicin—stomach cancer	0.00228	0.00346	CcSEcCtD
Methyl aminolevulinate—Eye pain—Doxorubicin—stomach cancer	0.00227	0.00344	CcSEcCtD
Methyl aminolevulinate—Oedema—Fluorouracil—stomach cancer	0.00224	0.00339	CcSEcCtD
Methyl aminolevulinate—Infection—Fluorouracil—stomach cancer	0.00223	0.00337	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IRF1—stomach cancer	0.00221	0.00651	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRS2—stomach cancer	0.00221	0.0065	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TXNIP—stomach cancer	0.0022	0.00646	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSC—stomach cancer	0.00215	0.00634	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MT2A—stomach cancer	0.00215	0.00634	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis bullous—Doxorubicin—stomach cancer	0.00215	0.00325	CcSEcCtD
Methyl aminolevulinate—Face oedema—Epirubicin—stomach cancer	0.00214	0.00324	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Docetaxel—stomach cancer	0.00213	0.00322	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Irinotecan—stomach cancer	0.0021	0.00318	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Capecitabine—stomach cancer	0.00206	0.00312	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6ST—stomach cancer	0.00203	0.00597	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Irinotecan—stomach cancer	0.00202	0.00305	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Fluorouracil—stomach cancer	0.00201	0.00305	CcSEcCtD
Methyl aminolevulinate—Pain—Irinotecan—stomach cancer	0.002	0.00303	CcSEcCtD
Methyl aminolevulinate—Face oedema—Doxorubicin—stomach cancer	0.00198	0.003	CcSEcCtD
Methyl aminolevulinate—Erythema—Docetaxel—stomach cancer	0.00198	0.003	CcSEcCtD
Methyl aminolevulinate—Erythema—Capecitabine—stomach cancer	0.00192	0.0029	CcSEcCtD
Methyl aminolevulinate—Pain—Fluorouracil—stomach cancer	0.00192	0.0029	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Methotrexate—stomach cancer	0.00187	0.00283	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CASP10—stomach cancer	0.00182	0.00536	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6R—stomach cancer	0.00181	0.00533	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HBEGF—stomach cancer	0.00181	0.00531	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Fluorouracil—stomach cancer	0.00178	0.0027	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MX1—stomach cancer	0.00175	0.00517	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Epirubicin—stomach cancer	0.00175	0.00265	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HBEGF—stomach cancer	0.00173	0.0051	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Irinotecan—stomach cancer	0.00172	0.00261	CcSEcCtD
Methyl aminolevulinate—Asthenia—Irinotecan—stomach cancer	0.00168	0.00254	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MAPK3—stomach cancer	0.00165	0.00486	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Fluorouracil—stomach cancer	0.00165	0.0025	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PPP2R1A—stomach cancer	0.00163	0.00481	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00162	0.00245	CcSEcCtD
Methyl aminolevulinate—Oedema—Docetaxel—stomach cancer	0.00162	0.00245	CcSEcCtD
Methyl aminolevulinate—Discomfort—Capecitabine—stomach cancer	0.00161	0.00244	CcSEcCtD
Methyl aminolevulinate—Infection—Docetaxel—stomach cancer	0.00161	0.00243	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—BIRC2—stomach cancer	0.0016	0.00471	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSL—stomach cancer	0.00159	0.00467	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Fluorouracil—stomach cancer	0.00159	0.0024	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PPP2R1A—stomach cancer	0.00157	0.00462	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Capecitabine—stomach cancer	0.00157	0.00237	CcSEcCtD
Methyl aminolevulinate—Infection—Capecitabine—stomach cancer	0.00156	0.00236	CcSEcCtD
Methyl aminolevulinate—Dizziness—Irinotecan—stomach cancer	0.00155	0.00234	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MALT1—stomach cancer	0.00155	0.00455	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—LGALS3—stomach cancer	0.00153	0.00452	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Methotrexate—stomach cancer	0.00153	0.00232	CcSEcCtD
Methyl aminolevulinate—Dizziness—Fluorouracil—stomach cancer	0.00148	0.00224	CcSEcCtD
Methyl aminolevulinate—Rash—Irinotecan—stomach cancer	0.00147	0.00223	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Irinotecan—stomach cancer	0.00147	0.00223	CcSEcCtD
Methyl aminolevulinate—Headache—Irinotecan—stomach cancer	0.00147	0.00222	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Docetaxel—stomach cancer	0.00145	0.0022	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FYN—stomach cancer	0.00144	0.00424	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Epirubicin—stomach cancer	0.00143	0.00217	CcSEcCtD
Methyl aminolevulinate—Erythema—Methotrexate—stomach cancer	0.00143	0.00216	CcSEcCtD
Methyl aminolevulinate—Rash—Fluorouracil—stomach cancer	0.00141	0.00214	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Fluorouracil—stomach cancer	0.00141	0.00214	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Capecitabine—stomach cancer	0.00141	0.00213	CcSEcCtD
Methyl aminolevulinate—Headache—Fluorouracil—stomach cancer	0.0014	0.00213	CcSEcCtD
Methyl aminolevulinate—Fatigue—Docetaxel—stomach cancer	0.00139	0.00211	CcSEcCtD
Methyl aminolevulinate—Nausea—Irinotecan—stomach cancer	0.00139	0.0021	CcSEcCtD
Methyl aminolevulinate—Pain—Docetaxel—stomach cancer	0.00138	0.00209	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FYN—stomach cancer	0.00138	0.00407	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—stomach cancer	0.00138	0.00405	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGFR2—stomach cancer	0.00135	0.00398	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Capecitabine—stomach cancer	0.00135	0.00204	CcSEcCtD
Methyl aminolevulinate—Pain—Capecitabine—stomach cancer	0.00134	0.00203	CcSEcCtD
Methyl aminolevulinate—Erythema—Epirubicin—stomach cancer	0.00134	0.00202	CcSEcCtD
Methyl aminolevulinate—Nausea—Fluorouracil—stomach cancer	0.00133	0.00202	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Doxorubicin—stomach cancer	0.00133	0.00201	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGFR2—stomach cancer	0.0013	0.00382	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IRF1—stomach cancer	0.00129	0.00379	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Capecitabine—stomach cancer	0.00124	0.00188	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IRS2—stomach cancer	0.00124	0.00364	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Doxorubicin—stomach cancer	0.00124	0.00187	CcSEcCtD
Methyl aminolevulinate—Discomfort—Methotrexate—stomach cancer	0.0012	0.00182	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL1RN—stomach cancer	0.0012	0.00353	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Docetaxel—stomach cancer	0.00119	0.0018	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—IRS2—stomach cancer	0.00119	0.0035	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Docetaxel—stomach cancer	0.00116	0.00176	CcSEcCtD
Methyl aminolevulinate—Infection—Methotrexate—stomach cancer	0.00116	0.00175	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—stomach cancer	0.00115	0.0034	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Capecitabine—stomach cancer	0.00115	0.00175	CcSEcCtD
Methyl aminolevulinate—Pruritus—Docetaxel—stomach cancer	0.00114	0.00173	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6ST—stomach cancer	0.00114	0.00335	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Epirubicin—stomach cancer	0.00112	0.0017	CcSEcCtD
Methyl aminolevulinate—Asthenia—Capecitabine—stomach cancer	0.00112	0.0017	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD44—stomach cancer	0.00112	0.00329	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Capecitabine—stomach cancer	0.00111	0.00168	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAPK3—stomach cancer	0.0011	0.00325	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PRKCB—stomach cancer	0.0011	0.00323	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Epirubicin—stomach cancer	0.00109	0.00165	CcSEcCtD
Methyl aminolevulinate—Infection—Epirubicin—stomach cancer	0.00108	0.00164	CcSEcCtD
Methyl aminolevulinate—Dizziness—Docetaxel—stomach cancer	0.00107	0.00162	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HBEGF—stomach cancer	0.00105	0.0031	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAPK1—stomach cancer	0.00105	0.00309	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Methotrexate—stomach cancer	0.00105	0.00158	CcSEcCtD
Methyl aminolevulinate—Discomfort—Doxorubicin—stomach cancer	0.00104	0.00158	CcSEcCtD
Methyl aminolevulinate—Dizziness—Capecitabine—stomach cancer	0.00104	0.00157	CcSEcCtD
Methyl aminolevulinate—Rash—Docetaxel—stomach cancer	0.00102	0.00154	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Docetaxel—stomach cancer	0.00102	0.00154	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CASP8—stomach cancer	0.00102	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6R—stomach cancer	0.00101	0.00299	CbGpPWpGaD
Methyl aminolevulinate—Headache—Docetaxel—stomach cancer	0.00101	0.00153	CcSEcCtD
Methyl aminolevulinate—Oedema—Doxorubicin—stomach cancer	0.00101	0.00153	CcSEcCtD
Methyl aminolevulinate—Fatigue—Methotrexate—stomach cancer	0.001	0.00152	CcSEcCtD
Methyl aminolevulinate—Infection—Doxorubicin—stomach cancer	0.001	0.00152	CcSEcCtD
Methyl aminolevulinate—Pain—Methotrexate—stomach cancer	0.000997	0.00151	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—KRAS—stomach cancer	0.000991	0.00292	CbGpPWpGaD
Methyl aminolevulinate—Rash—Capecitabine—stomach cancer	0.000987	0.00149	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Capecitabine—stomach cancer	0.000986	0.00149	CcSEcCtD
Methyl aminolevulinate—Headache—Capecitabine—stomach cancer	0.000981	0.00149	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Epirubicin—stomach cancer	0.000979	0.00148	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDH1—stomach cancer	0.000966	0.00284	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Docetaxel—stomach cancer	0.00096	0.00145	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PPP2R1A—stomach cancer	0.000951	0.0028	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Epirubicin—stomach cancer	0.00094	0.00142	CcSEcCtD
Methyl aminolevulinate—Pain—Epirubicin—stomach cancer	0.000933	0.00141	CcSEcCtD
Methyl aminolevulinate—Nausea—Capecitabine—stomach cancer	0.00093	0.00141	CcSEcCtD
Methyl aminolevulinate—Urticaria—Methotrexate—stomach cancer	0.000926	0.0014	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—stomach cancer	0.00091	0.00268	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Doxorubicin—stomach cancer	0.000906	0.00137	CcSEcCtD
Methyl aminolevulinate—Fatigue—Doxorubicin—stomach cancer	0.00087	0.00132	CcSEcCtD
Methyl aminolevulinate—Urticaria—Epirubicin—stomach cancer	0.000866	0.00131	CcSEcCtD
Methyl aminolevulinate—Pain—Doxorubicin—stomach cancer	0.000863	0.00131	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Methotrexate—stomach cancer	0.000859	0.0013	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ERBB2—stomach cancer	0.000848	0.0025	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HRAS—stomach cancer	0.000842	0.00248	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FYN—stomach cancer	0.000838	0.00247	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Methotrexate—stomach cancer	0.000836	0.00127	CcSEcCtD
Methyl aminolevulinate—Pruritus—Methotrexate—stomach cancer	0.000825	0.00125	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ERBB2—stomach cancer	0.000815	0.0024	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—stomach cancer	0.000806	0.00237	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Epirubicin—stomach cancer	0.000804	0.00122	CcSEcCtD
Methyl aminolevulinate—Urticaria—Doxorubicin—stomach cancer	0.000802	0.00121	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGFR2—stomach cancer	0.000787	0.00232	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1B—stomach cancer	0.000786	0.00231	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Epirubicin—stomach cancer	0.000783	0.00119	CcSEcCtD
Methyl aminolevulinate—Pruritus—Epirubicin—stomach cancer	0.000772	0.00117	CcSEcCtD
Methyl aminolevulinate—Dizziness—Methotrexate—stomach cancer	0.000771	0.00117	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1B—stomach cancer	0.000754	0.00222	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JUN—stomach cancer	0.000748	0.0022	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Doxorubicin—stomach cancer	0.000743	0.00113	CcSEcCtD
Methyl aminolevulinate—Rash—Methotrexate—stomach cancer	0.000735	0.00111	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Methotrexate—stomach cancer	0.000734	0.00111	CcSEcCtD
Methyl aminolevulinate—Headache—Methotrexate—stomach cancer	0.00073	0.00111	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1A—stomach cancer	0.000725	0.00213	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Doxorubicin—stomach cancer	0.000724	0.0011	CcSEcCtD
Methyl aminolevulinate—Dizziness—Epirubicin—stomach cancer	0.000721	0.00109	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IRS2—stomach cancer	0.000721	0.00212	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Doxorubicin—stomach cancer	0.000714	0.00108	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK8—stomach cancer	0.000708	0.00208	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1A—stomach cancer	0.000696	0.00205	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Methotrexate—stomach cancer	0.000692	0.00105	CcSEcCtD
Methyl aminolevulinate—Rash—Epirubicin—stomach cancer	0.000688	0.00104	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Epirubicin—stomach cancer	0.000687	0.00104	CcSEcCtD
Methyl aminolevulinate—Headache—Epirubicin—stomach cancer	0.000683	0.00103	CcSEcCtD
Methyl aminolevulinate—Dizziness—Doxorubicin—stomach cancer	0.000667	0.00101	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCB—stomach cancer	0.000665	0.00196	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6ST—stomach cancer	0.000662	0.00195	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Epirubicin—stomach cancer	0.000648	0.000981	CcSEcCtD
Methyl aminolevulinate—Rash—Doxorubicin—stomach cancer	0.000636	0.000964	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Doxorubicin—stomach cancer	0.000636	0.000963	CcSEcCtD
Methyl aminolevulinate—Headache—Doxorubicin—stomach cancer	0.000632	0.000957	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK3—stomach cancer	0.000618	0.00182	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Doxorubicin—stomach cancer	0.000599	0.000908	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CASP8—stomach cancer	0.000593	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6R—stomach cancer	0.000591	0.00174	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK1—stomach cancer	0.000588	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EGFR—stomach cancer	0.000588	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CDH1—stomach cancer	0.000586	0.00172	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EGFR—stomach cancer	0.000565	0.00166	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KRAS—stomach cancer	0.000556	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KRAS—stomach cancer	0.000533	0.00157	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—stomach cancer	0.00051	0.0015	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ERBB2—stomach cancer	0.000494	0.00145	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—stomach cancer	0.00049	0.00144	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HRAS—stomach cancer	0.000472	0.00139	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1B—stomach cancer	0.000458	0.00135	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HRAS—stomach cancer	0.000453	0.00133	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—stomach cancer	0.000452	0.00133	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—stomach cancer	0.00045	0.00132	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—JUN—stomach cancer	0.000436	0.00128	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1A—stomach cancer	0.000422	0.00124	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK8—stomach cancer	0.000412	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—stomach cancer	0.000377	0.00111	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK3—stomach cancer	0.00036	0.00106	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK1—stomach cancer	0.000343	0.00101	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EGFR—stomach cancer	0.000343	0.00101	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—KRAS—stomach cancer	0.000324	0.000953	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—stomach cancer	0.000297	0.000875	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HRAS—stomach cancer	0.000275	0.00081	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—stomach cancer	0.000263	0.000775	CbGpPWpGaD
